Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
United States Air Force
With
Alcon Research
Age
Any age
Sex
ALL
Healthy volunteers
Accepted
You may be eligible if
patient must already be using xalatan for at least 1 month prior to study enrollment in both eyes and have complaints of dry eye and/or irritation.
study population:
any race and of either sex, diagnosed with open angle glaucoma (OAG) (with or without pseudoexfoliation or pigment dispersion components) or ocular hypertension (OHT)
tear break up times (TBUT) \< 6 seconds on xalatan monotherapy.
You may not be if
unequal baseline measurements (i.e. difference in cup to disc ratio of .1 or greater, intraocular pressure difference of 2 or more mm Hg),
difference in subjective symptoms of dryness/irritation between the patient's two eyes;
history of ocular trauma or intraocular surgery within the past 6 months in either eye;
ocular infection, ocular inflammation, or ocular laser surgery within the past 3 months in either eye;
severe hypersensitivity to study medications or vehicle;
any abnormality preventing reliable applanation tonometry;
anterior chamber angle less than 10 degrees in either eye,
severe central visual field loss in either eye;
cup-to-disc ratio greater than 0.80 in either eye;
contraindications to pupil dilation; previous diagnosis of autoimmune diseases;
chronic glucocorticoid use within 1 month of and during the eligibility phase or intermittent glucocorticoid use within 2 weeks of the eligibility phase;
any type of glaucoma other than OAG or OHT;
therapy with another investigational agent within 30 days of study start;
use of any other topical or systemic ocular hypotensive medication during the study.
Clareo Health | Dry Eye and Irritation Comparison of Latanoprost With the Preservative Versus Travoprost Without Preservative
